Insmed Incorporated ( INSM) - Key Metrics
INSM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.96 | -$0.06 | -$0.41 | -$0.44 |
| 2026Q1 | $1.42 | -$0.76 | -$1.03 | -$1.05 |
| 2025Q4 | $1.24 | -$1.54 | -$1.16 | -$1.38 |
| 2025Q3 | $0.67 | -$1.75 | -$1.04 | -$1.05 |
| 2025Q2 | $0.57 | -$1.70 | -$1.09 | -$1.10 |
INSM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -444.25 |
| 2026Q1 | 0% | -53.79 |
| 2025Q4 | 0% | -28.25 |
| 2025Q3 | 0% | -20.57 |
| 2025Q2 | 0% | -14.80 |
INSM
Price: $123.74
52 week price:
Earnings Per Share: -4.12 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.3 million
Ebitda: -42.9 millionMarket Capitalization: 29.0 billion